Pharmacytimes: Condition Center: Mental Health Mental Health en-us Sun, 21 Jan 2018 02:51:54 UTC Sun, 21 Jan 2018 02:51:54 UTC The Proven Health Benefits of Yoga and Meditation Discover how a mindfulness practice can improve a person&#39;s quality of life. 10:00 AM, Sat January 20, 2018 Allergan, Gedeon Richter Plan to Submit Cariprazine sNDA for Depression Officials with Allergan and Gedeon Richter are reporting positive topline results for a phase 3 study of cariprazine (Vraylar) for the treatment of adults with bipolar I depression.<br /> &nbsp; 2:00 AM, Wed December 20, 2017 Perinatal HIV Infection: Nonadherence Risk Increases in Adolescents Adolescents and young adults who are living with HIV and were exposed to the virus perinatally have a unique risk of nonadherence in adolescence, as well as an elevated risk of mental health and substance use problems.&nbsp; 10:20 AM, Fri December 15, 2017 Stressed Out At Work? Ways to Cope with Challenges Here are some ways to cope with any stress or challenges that community pharmacy may bring. 4:46 AM, Wed November 29, 2017 What the WHO Essentials List Means for Mental Health One glaring omission is the lack of psychiatric medications included.<br /> &nbsp; 8:00 AM, Fri November 24, 2017 What Pharmacists Should Know About the Abilify MyCite Pill With the smart tablets coming to market in 2018, it is a good time to explore how the technology behind the product works. 2:34 AM, Fri November 17, 2017 10 Natural Remedies to Consider for Treating Anxiety Here is how to go beyond conventional medicine to help those who suffer from the leading mental health disorder in the United States. 12:06 AM, Thu October 26, 2017 5 Psychiatry Studies Pharmacists Should Know About Over the years, a number of landmark clinical studies in the field of psychiatry have been published, shaping how we treat mental illness. Here are 5 that every pharmacist should know about. 3:47 AM, Wed September 20, 2017 Pharmacists Can Play Important Role in Depression Screening According to the US Preventive Services Task Force&#39;s (USPSTF) updated recommendations for depression screening in adults, major depressive disorder is the leading cause of disability among adults in high-income countries. 3:10 PM, Sun September 3, 2017 What is the National Council on Patient Information and Education? Here is the 411 on this organization, which offers programs to help consumers better understand their medications. 11:36 PM, Wed August 23, 2017 Management of Psychosis in Parkinson's Disease: Clinical Tidbits What are the best practice considerations for managing Parkinson's Psychosis? 11:26 PM, Tue May 9, 2017 Carving Out a Niche in the Treatment of Tardive Dyskinesia The FDA recently approved Ingrezza (valbenazine) for the treatment of adults with tardive dyskinesia. 1:33 AM, Wed May 3, 2017 5 Interesting Medication Case Reports - Part 3 This article highlights 5 published case reports that document unusually high doses of medications that are not often seen in clinical practice. 9:54 PM, Wed April 26, 2017 Fighting the Stigma Around Mental Illness What are you doing to stop the stigma surrounding mental illnesses? 10:46 PM, Mon February 20, 2017 The Key to Better Bipolar I Disorder Control? What can you (or your pharmacist) do to improve Bipolar I Disorder outcomes? 8:20 PM, Sun February 12, 2017 Study Notes Missed Opportunity for HIV Detection A new study, published in <em>Psychiatric Services,</em> reveals a missed opportunity for early HIV detection and treatment.&nbsp; 9:44 AM, Tue January 24, 2017 Ajanta Launches Generic Abilify in US Market Ajanta has launched&nbsp;aripiprazole tablets in 2.5-mg, 5-mg, 10-mg, 15-mg, 20-mg, and 30-mg doses in the United States. 7:00 AM, Tue November 29, 2016 Study Shows More Than 50% of Americans Have at Least 1 Chronic Health Condition, Mental Disorder, or Substance Use Issue <p>The election has brought discussion about the complexity of the US health care system to the forefront. A new study from <em>Psychology, Health &amp; Medicine</em> reveals just how intricate the medical needs of Americans really are.</p> 11:04 AM, Tue November 8, 2016 FDA Approves sNDA for Label Changes to ADASUVE The FDA has approved the supplemental New Drug Application for label changes to ADASUVE (loxapine) inhalation powder. 7:00 AM, Mon October 24, 2016 Vraylar The FDA has approved Vraylar, an atypical antipsychotic, for the treatment of schizophrenia and the acute treatment of mixed or manic episodes associated with bipolar I disorder. 5:25 AM, Fri May 13, 2016